Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran

• Main Authors: Leung TS (Author), Law EH (Author)
• Formato: Libro
• Publicado: Dove Medical Press, 2015-07-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Timothy S Leung,1 Ernest H Law2 1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; 2Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA Abstract: Venous thromboembolism includes deep ve...